Cognitive Connie
Epidemiology of Anxiety Disorders
Anxiety disorders are the most prevalent mental health conditions worldwide. Understanding who is affected, when disorders begin, and how they co-occur with other conditions is essential for grasping their full clinical and public health significance — and for interpreting the research literature.
Key figures
Michelle Craske
Professor at UCLA and one of the world's leading anxiety researchers. Co-authored the 2016 Lancet review that established the key epidemiological benchmarks for anxiety disorders used in this theme. Her research spans the etiology, treatment, and prevention of anxiety disorders.
Murray Stein
Psychiatrist and epidemiologist at UC San Diego, co-author of the Craske & Stein (2016) Lancet review on anxiety disorders. His work on the prevalence, burden, and treatment of anxiety disorders has been central to shaping understanding of their global public health impact.
Key concepts
Most prevalent mental health condition
Anxiety disorders are the most prevalent mental health condition globally. Their high population prevalence reflects both their early age of onset and their chronic, often untreated course. They impose a substantial burden on quality of life, work, and relationships.
Age of onset
Anxiety disorders mostly begin during childhood, adolescence, and early adulthood. Specific phobia and separation anxiety typically emerge in childhood; social anxiety disorder peaks in adolescence; panic disorder and GAD more often begin in early adulthood. Early onset means individuals frequently live with the condition for decades before receiving effective treatment.
Gender differences: 2:1 ratio
Women are approximately twice as likely as men to have an anxiety disorder. This 2:1 female-to-male ratio is one of the most consistent findings in psychiatric epidemiology. Proposed explanations include hormonal factors, differences in cognitive appraisal, greater propensity to internalise stress, and sociocultural influences on help-seeking and diagnosis.
Anxiety as a dimensional construct
Anxiety is a dimensional construct — it exists on a continuum of severity across the general population. Categorical diagnostic criteria (DSM-5, ICD-10) represent clinically useful cut-points on this dimension rather than natural boundaries. Subclinical anxiety still impairs functioning, and individuals move across diagnostic thresholds over time.
Specific Phobia: most common anxiety disorder (6–12%)
Specific Phobia is the most common anxiety disorder, with lifetime prevalence estimates of 6–12%. Most individuals with Specific Phobia have more than one phobia. Despite its high prevalence, Specific Phobia often goes untreated because sufferers can manage by avoidance rather than seeking help.
Social Anxiety Disorder: second most common (10%)
Social Anxiety Disorder has a lifetime prevalence of approximately 10%, making it the second most common anxiety disorder. Compared to most other anxiety disorders, there is less discrepancy in rates between men and women — the typical 2:1 female excess is attenuated.
GAD lifetime prevalence: 3–5%
Generalised Anxiety Disorder has a lifetime prevalence of approximately 3–5%, placing it below Specific Phobia and Social Anxiety Disorder. Despite its lower prevalence, GAD is associated with considerable disability because pervasive worry about multiple life domains affects functioning across the board.
Panic Disorder lifetime prevalence: 2–5%
Panic Disorder has a lifetime prevalence of approximately 2–5%. It is associated with marked behavioural change — particularly avoidance of situations where panic attacks have occurred — and significant disability. It frequently co-occurs with Agoraphobia.
Separation Anxiety lifetime prevalence: 2–3%
Separation Anxiety Disorder has a lifetime prevalence of approximately 2–3%. While classically associated with childhood, DSM-5 recognises adult presentations. Adults with separation anxiety may avoid travel, independent living, or occupational situations that involve separation from attachment figures.
Agoraphobia lifetime prevalence: 2%
Agoraphobia has a lifetime prevalence of approximately 2%. In DSM-5, it is a standalone diagnosis separate from Panic Disorder. Agoraphobia often severely limits functioning because sufferers may become housebound or unable to use public transport, open spaces, or crowded places.
Comorbidity among anxiety disorders
Comorbidity among anxiety disorders is common — as many as half of individuals with one anxiety disorder will have another at some point in their life. This high within-category comorbidity is consistent with a shared vulnerability model: a general negative affect or anxiety sensitivity diathesis that expresses itself across multiple disorder subtypes.
Comorbidity with depression
Anxiety disorders frequently co-occur with depression. The two categories share genetic risk, neurobiological pathways, and cognitive vulnerabilities. In clinical samples, comorbid presentations are the norm rather than the exception, and the presence of both conditions is associated with greater severity and worse treatment outcomes than either alone.
GAD–depression link: particularly strong
The association between GAD and Major Depressive Disorder is particularly strong — stronger than for other anxiety disorders. They share overlapping diagnostic criteria, high genetic overlap, and frequently co-occur temporally. Some researchers argue they may reflect a common internalising disorder rather than two truly distinct conditions.
Substance use comorbidity: present but less than depression
Alcohol and substance-use disorders are also comorbid with anxiety disorders, often reflecting self-medication of anxiety symptoms. However, this comorbidity is less pronounced than the anxiety–depression relationship. The direction of causation is complex and bidirectional: anxiety may drive substance use, but substance intoxication and withdrawal can also generate or worsen anxiety.
Test your knowledge
Frequently asked questions
Why are anxiety disorders the most prevalent mental health condition?+
Several factors contribute. Anxiety disorders have a broad diagnostic umbrella — covering numerous distinct conditions — and many begin early in life, meaning individuals accumulate years of disorder. They are also under-treated: avoidance behaviour, which is a core maintaining mechanism, also reduces help-seeking. Social stigma and poor recognition in primary care contribute further. Finally, anxiety is an evolutionarily conserved threat-detection system; small elevations above adaptive levels can tip into disorder without a clear biological discontinuity, consistent with the dimensional nature of the construct.
Why is the association between GAD and depression so much stronger than for other anxiety disorders?+
GAD and Major Depressive Disorder share multiple features: both involve persistent negative affect, cognitive rumination, sleep disturbance, fatigue, and concentration difficulties. Twin studies show substantial genetic overlap between the two conditions — to the extent that some researchers suggest they share a common genetic diathesis. The "excessive, uncontrollable worry" of GAD is phenomenologically close to the rumination and hopeless future-orientation of depression. By contrast, specific phobia and panic disorder involve more acute, situationally-triggered fear responses that are phenomenologically distinct from the sustained low mood of MDD, explaining their weaker statistical association.
Why do women have anxiety disorders at twice the rate of men?+
The 2:1 female-to-male ratio is one of the most robust findings in psychiatric epidemiology and is unlikely to have a single cause. Hormonal factors are implicated: oestrogen and progesterone interact with the fear and stress circuitry (amygdala, HPA axis), and anxiety is often elevated during luteal phase, postpartum, and perimenopausal periods. Cognitive factors also matter: women on average show greater threat sensitivity and are more prone to internalising emotional distress rather than externalising it. Sociocultural factors — including gender-differentiated exposure to trauma and adversity — add further risk. Reporting and help-seeking differences may inflate the measured ratio somewhat, but most researchers believe the gap reflects genuine differences in vulnerability and not only ascertainment bias.
Sources
Last reviewed July 2025- 1.
Craske, M. G., & Stein, M. B. (2016). Anxiety. Lancet, 388(10063), 3048–3059. https://doi.org/10.1016/S0140-6736(16)30381-6
+About this source
Landmark review providing the prevalence estimates, gender differences, onset patterns, and comorbidity data used throughout this theme.